A detailed history of Noesis Capital Mangement Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Noesis Capital Mangement Corp holds 112,151 shares of MRK stock, worth $11.2 Million. This represents 2.53% of its overall portfolio holdings.

Number of Shares
112,151
Previous 101,120 10.91%
Holding current value
$11.2 Million
Previous $12.5 Billion 1.74%
% of portfolio
2.53%
Previous 2.78%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $1.23 Million - $1.42 Million
11,031 Added 10.91%
112,151 $12.7 Billion
Q2 2024

Aug 05, 2024

SELL
$123.8 - $132.96 $12,751 - $13,694
-103 Reduced 0.1%
101,120 $12.5 Billion
Q1 2024

May 03, 2024

SELL
$113.24 - $131.95 $156,157 - $181,959
-1,379 Reduced 1.34%
101,223 $13.4 Billion
Q4 2023

Feb 06, 2024

SELL
$100.18 - $109.02 $43,778 - $47,641
-437 Reduced 0.42%
102,602 $11.2 Billion
Q3 2023

Nov 03, 2023

BUY
$102.95 - $114.33 $142,997 - $158,804
1,389 Added 1.37%
103,039 $10.6 Billion
Q2 2023

Jul 31, 2023

BUY
$108.61 - $118.38 $9,774 - $10,654
90 Added 0.09%
101,650 $11.7 Billion
Q1 2023

May 08, 2023

BUY
$102.94 - $114.86 $10.1 Million - $11.3 Million
97,984 Added 2740.04%
101,560 $10.8 Billion
Q4 2022

Feb 02, 2023

SELL
$87.44 - $112.11 $21,335 - $27,354
-244 Reduced 6.39%
3,576 $397 Million
Q3 2022

Nov 01, 2022

SELL
$84.53 - $94.96 $20,625 - $23,170
-244 Reduced 6.0%
3,820 $329 Million
Q2 2022

Jul 29, 2022

SELL
$83.49 - $94.64 $451,430 - $511,718
-5,407 Reduced 57.09%
4,064 $370,000
Q1 2022

May 05, 2022

SELL
$73.51 - $82.4 $393,719 - $441,334
-5,356 Reduced 36.12%
9,471 $777,000
Q4 2021

Feb 03, 2022

SELL
$72.28 - $90.54 $372,964 - $467,186
-5,160 Reduced 25.82%
14,827 $1.14 Million
Q3 2021

Nov 04, 2021

BUY
$71.68 - $78.83 $118,272 - $130,069
1,650 Added 9.0%
19,987 $1.5 Million
Q2 2021

Aug 05, 2021

SELL
$70.31 - $77.77 $1,828 - $2,022
-26 Reduced 0.14%
18,337 $1.43 Million
Q1 2021

May 06, 2021

BUY
$68.86 - $81.11 $54,330 - $63,995
789 Added 4.49%
18,363 $1.35 Million
Q4 2020

Feb 04, 2021

BUY
$71.77 - $79.65 $7,894 - $8,761
110 Added 0.63%
17,574 $1.37 Million
Q2 2020

Aug 07, 2020

SELL
$70.42 - $80.13 $6,126 - $6,971
-87 Reduced 0.5%
17,464 $1.29 Million
Q1 2020

May 06, 2020

SELL
$63.36 - $87.82 $38,016 - $52,691
-600 Reduced 3.31%
17,551 $1.29 Million
Q4 2019

Feb 07, 2020

SELL
$77.58 - $87.54 $15,516 - $17,508
-200 Reduced 1.09%
18,151 $1.65 Million
Q3 2019

Nov 05, 2019

BUY
$76.08 - $82.93 $14,683 - $16,005
193 Added 1.06%
18,351 $1.47 Million
Q2 2019

Aug 06, 2019

BUY
$69.84 - $81.59 $38,551 - $45,037
552 Added 3.14%
18,158 $0
Q1 2019

May 09, 2019

SELL
$69.58 - $79.36 $55,664 - $63,488
-800 Reduced 4.35%
17,606 $0
Q2 2018

Aug 13, 2018

BUY
$50.83 - $59.72 $2,439 - $2,866
48 Added 0.26%
18,406 $1.12 Million
Q1 2018

May 07, 2018

SELL
$50.96 - $59.23 $5,401 - $6,278
-106 Reduced 0.57%
18,358 $1 Million
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $4,232 - $5,054
82 Added 0.45%
18,464 $1.04 Million
Q3 2017

Nov 07, 2017

SELL
$58.67 - $63.13 $11,616 - $12,499
-198 Reduced 1.07%
18,382 $1.18 Million
Q2 2017

Aug 10, 2017

BUY
N/A
18,580
18,580 $1.19 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Noesis Capital Mangement Corp Portfolio

Follow Noesis Capital Mangement Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Noesis Capital Mangement Corp, based on Form 13F filings with the SEC.

News

Stay updated on Noesis Capital Mangement Corp with notifications on news.